Legal Representation
Attorney
B. Brett Heavner
USPTO Deadlines
Application History
13 eventsDate | Code | Type | Description |
---|---|---|---|
Oct 23, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Oct 23, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Mar 21, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Jan 24, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jan 24, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jan 4, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Dec 17, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
Dec 17, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Dec 1, 2022 | ALIE | A | ASSIGNED TO LIE |
Dec 1, 2022 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
Oct 20, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Oct 12, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED |
Oct 7, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005